FDA approves Opzelura for repigmentation in nonsegmental vitiligo Dr. Kamal Kant Kohli21 July 2022 9:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved Opzelura (ruxolitinib) cream 1.5% for the topical treatment of nonsegmental vitiligo in adult...
Novartis gets European Commission nod for Jakavi to treat acute, chronic graft-versus-host disease Ruchika Sharma8 May 2022 10:15 AM ISTGvHD occurs when donor cells see the recipient's healthy cells as foreign and attack them.
Ruxolitinib cream highly effective in treatment of cutaneous lichen planus: Study Medha Baranwal8 March 2022 9:00 AM ISTArizona: Topical ruxolitinib is highly effective for treating cutaneous lichen planus (LP), according to findings from a small pilot study in the...
Topical JAK and PDE4 inhibitors promising treatments for Atopic dermatitis: Study MD Editorial Team22 Oct 2021 9:00 AM ISTChina: Topical Janus kinase (JAK) and phosphodiesterase-4 (PDE4) inhibitors are novel treatment approaches for atopic dermatitis (AD).A new study...
FDA Approves ruxolitinib cream for treatment of Atopic Dermatitis Dr Kartikeya Kohli22 Sept 2021 9:30 PM ISTThe US food and drug administration has approved a topical selective Janus kinase (JAK)1/JAK2 inhibitor ruxolitinib (Opzelura) for the treatment of...
Tofacitinib and ruxolitinib show efficacy in alopecia areata: shows meta-analysis Dr Manoj Kumar Nayak15 Sept 2021 9:30 AM ISTTofacitinib and ruxolitinib show efficacy in alopecia areata: shows meta-analysis Alopecia areata is a common disorder of hair loss, treatment of...
High risk HPV strain linked to ruxolitinib associated sebaceous neoplasms: IJDVL study Dr Manoj Kumar Nayak9 July 2021 9:00 AM ISTHigh‑risk HPV strain may cause ruxolitinib‑associated sebaceous neoplasms, finds a IJDVL study Ruxolitinib is a JAK1/2 inhibitor approved for...
Ruxolitinib Cream shows positive results in patients with Vitiligo Dr. Nandita Mohan20 May 2021 9:00 AM ISTA recent Phase 3 TRuE-V clinical trial program revealed that patients treated with ruxolitinib cream 1.5% twice daily (BID) achieved a ≥75%...
Ruxolitinib cream effective for vitiligo treatment Medha Baranwal14 July 2020 10:41 AM ISTUSA: Ruxolitinib cream might be an effective treatment option for patients with vitiligo, suggests a recent study published in the journal LANCET. The...
FDA-approved drugs promise new hair growth Meghna A Singhania25 Oct 2015 11:29 PM ISTNew York: There is good news for people suffering from hair loss. In experiments with mouse and human hair follicles, researchers have found that...
